Not applicableStudy completedNCT02921035
What this trial is testing
Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)
Who this might be right for
Relapsing Multiple Sclerosis (RMS)
Merck KGaA, Darmstadt, Germany 594